Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4jlk.1

Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-METHYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.89 Å
Oligo State
homo-dimer
Ligands
2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
4 x 1NO: 2-[({2-[3-(2-fluoroethoxy)-4-methoxyphenyl]-5-methyl-1,3-thiazol-4-yl}methyl)sulfanyl]pyrimidine-4,6-diamine(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Murphy, J.M. et al., Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. J.Med.Chem. (2013)
Release Date
2013-09-18
Peptides
Deoxycytidine kinase: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Deoxycytidine kinase

Related Entries With Identical Sequence

4jlj.1 | 4jlm.1 | 4jln.1 | 4kcg.1 | 4l5b.1 | 4q18.1 | 4q19.1 | 4q1a.1 | 4q1b.1 | 4q1c.1 | 4q1d.1 | 4q1e.1 | 4q1f.1 | 7zi1.1 | 7zi2.1 | 7zi3.1 | 7zi5.1 | 7zi6.1 | 7zi7.1 | 7zi8.1 | 7zi9.1 | 7zia.1 | 7zib.1 | 8ooj.1 | 8ooj.2 | 8ooj.3